684PImpact of adjuvant treatment with nab-paclitaxel and gemcitabine (nab-P+GEM) vs gemcitabine alone (GEM) on health-related quality of life (QoL) in patients (pts) with surgically resected pancreatic adenocarcinoma (PA) in the adjuvant pancreatic adenocarcinoma clinical trial (APACT)
Riess, H, Braverman, J, Reni, M, Dueck, A C, Hendifar, A, Oh, D-Y, Li, C-P, Mercade, T Macarulla, Shah, A, Joshi, N, Botterman, M, Mantovani, E, Lu, B, Tempero, M AVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.012
Date:
October, 2019
File:
PDF, 112 KB
2019
File converter
More search results
More benefits 
